Volume 11 Issue 4
Jul.  2020
Turn off MathJax
Article Contents
An-li TONG, Han-zhong LI. Neuroendocrine Neoplasias Related to Hypertension: Current Status and Progress[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 361-364. doi: 10.3969/j.issn.1674-9081.2020.04.001
Citation: An-li TONG, Han-zhong LI. Neuroendocrine Neoplasias Related to Hypertension: Current Status and Progress[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 361-364. doi: 10.3969/j.issn.1674-9081.2020.04.001

Neuroendocrine Neoplasias Related to Hypertension: Current Status and Progress

doi: 10.3969/j.issn.1674-9081.2020.04.001
More Information
  • Corresponding author: LI Han-zhong  Tel: 86-10-69152510, E-mail:hzlipumch@163.com
  • Received Date: 2020-03-27
  • Publish Date: 2020-07-30
  • Neuroendocrine neoplasias (NENs) are rare. Some NENs secrete hormone, thus causing hypertension of the patients. NENs are important causes of secondary hypertension, which include pheochromocytoma and paraganglioma, growth hormone-secreting pituitary adenoma, adrenocorticotropic hormone-secreting pituitary adenoma, parathyroid adenoma and carcinoma, and ectopic hormone-secreting NENs. Apart from hypertension, most NEN patients had other typical clinical features that need to be identified at early stage. In recent years, with the application of new technologies of nuclide imaging, the detection rate of these diseases has been greatly improved, and more patients can be diagnosed and treated early.
  • loading
  • [1] 王连唐, 程嘉骧, 黄世章.内分泌病理学[M].江西:江西科学技术出版社, 2006:253-296.
    [2] 中华医学会内分泌学分会肾上腺学组.嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识[J].中华内分泌代谢杂志, 2016, 32:181-187. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhnfmdx201603002
    [3] Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma:characteristics and treatment[J]. Endocrinol Metab Clin North Am, 2011, 40:295-311. doi:  10.1016/j.ecl.2011.02.002
    [4] 樊华, 李汉忠, 纪志刚, 等.嗜铬细胞瘤/副神经节瘤术中血压骤升的临床特征分析(附单中心219例报告)[J].中华泌尿外科杂志, 2019, 40:267-271. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhmnwk201904007
    [5] Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2014, 99:1915-1942. doi:  10.1210/jc.2014-1498
    [6] 景红丽.生长抑素受体显像在嗜铬细胞瘤、副神经节瘤和肿瘤性骨软化症的临床应用研究[D].北京: 中国医学科学院北京协和医院, 2016.
    [7] Janssen I, Blanchet EM, Adams K, et al. Superiority of[68Ga]-DOTATATE PET/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma[J]. Clin Cancer Res, 2015, 21:3888-3895. doi:  10.1158/1078-0432.CCR-14-2751
    [8] 邓建华, 李汉忠.嗜铬细胞瘤/副神经节瘤基因突变相关遗传综合征[J].协和医学杂志, 2015, 6:161-165. http://d.wanfangdata.com.cn/periodical/xhyx201503001
    [9] Neumann HPH, Young WF, Eng C. Pheochromocytoma and paraganglioma[J]. N Engl J Med, 2019, 381:552-565. doi:  10.1056/NEJMra1806651
    [10] Colao A, Grasso LFS, Giustina A, et al. Acromegaly[J]. Nat Rev Dis Primers, 2019, 5:20. doi:  10.1038/s41572-019-0071-6
    [11] Puglisi S, Terzolo M. Hypertension and acromegaly[J]. Endocrinol Metab Clin North Am, 2019, 48:779-793. doi:  10.1016/j.ecl.2019.08.008
    [12] Vilar L, Vilar CF, Lyra R, et al. Acromegaly:clinical features at diagnosis[J]. Pituitary, 2017, 20:22-32. doi:  10.1007/s11102-016-0772-8
    [13] Katznelson L, Laws ER, Melmed S, et al. Acromegaly:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2014, 99:3933-3951. doi:  10.1210/jc.2014-2700
    [14] Zahr R, Fleseriu M. Updates in diagnosis and treatment of acromegaly[J]. Eur Endocrinol, 2018, 14:57-61. doi:  10.17925/EE.2018.14.2.57
    [15] Lloyd RV, Osamura RY, Kloppel G, et al. WHO classification of tumours of endocrine organs[M]. 4th ed. Lyon:International Agency for Research on Cancer, 2017:12-23.
    [16] Trouillas J, Jaffrain-Rea ML, Vasiljevic A, et al. How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020[J]. Cancers (Basel), 2020, 12. pii:E514.doi: 10.3390/cancers12020514.
    [17] Stelmachowska-Banas M, Glogowski M, Vasiljevic A, et al. Ectopic acromegaly due to growth hormone-releasing hormone secretion from bronchial carcinoid causing somatotroph hyperplasia and partial pituitary insufficiency[J]. Pol Arch Intern Med, 2019, 129:208-210.
    [18] 中华医学会内分泌学分会.库欣综合征专家共识(2001年)[J].中华内分泌代谢杂志, 2011, 28:96-102.
    [19] Barbot M, Ceccato F, Scaroni C. The pathophysiology and treatment of hypertension in patients with Cushing's syndrome[J]. Front Endocrinol (Lausanne), 2019, 10:321. doi:  10.3389/fendo.2019.00321
    [20] Araujo Castro M, Marazuela Azpiroz M. Two types of ectopic Cushing syndrome or a continuum? Review[J]. Pituitary, 2018, 21:535-544. doi:  10.1007/s11102-018-0894-2
    [21] Isidori AM, Sbardella E, Zatelli MC, et al. Conventional and nuclear medicine imaging in ectopic Cushing's syndrome:A systematic review[J]. J Clin Endocrinol Metab, 2015, 100:3231-3244. doi:  10.1210/JC.2015-1589
    [22] Kalla A, Krishnamoorthy P, Gopalakrishnan A, et al. Primary hyperparathyroidism predicts hypertension:Results from the National Inpatient Sample[J]. Int J Cardiol, 2017, 227:335-337. doi:  10.1016/j.ijcard.2016.11.080
    [23] Graff-Baker AN, Bridges LT, Chen Q, et al. Parathyroidectomy for patients with primary hyperparathyroidism and associations with hypertension[J]. JAMA Surg, 2019, 155:32-39. https://www.ncbi.nlm.nih.gov/pubmed/31596437
    [24] Fisher SB, Perrier ND. Primary hyperparathyroidism and hypertension[J]. Gland Surg, 2020, 9:142-149. doi:  10.21037/gs.2019.10.21
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (455) PDF downloads(71) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return